Multi-platform molecular profiling of 1,180 patients increases median overall survival and influences treatment decision in 53% of cases | Caris Life Sciences
Home / Research / Publications / Multi-platform molecular profiling of 1,180 patients increases median overall survival and influences treatment decision in 53% of cases

Publications

Multi-platform molecular profiling of 1,180 patients increases median overall survival and influences treatment decision in 53% of cases

Background

A prospective, observational study was initiated in 2009 with IRB approval to track outcomes and determine the clinical utility of multi-platform molecular profiling (MMP) across a variety of solid tumors. A secondary objective was to assess the impact of MMP on physicians’ treatment decisions.

Download Publication
Learn More
Name(Required)